SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,477,148 | -44.4% | 425,691 | -25.5% | 0.01% | -40.0% |
Q2 2023 | $2,656,977 | -13.5% | 571,393 | -14.0% | 0.02% | -21.1% |
Q1 2023 | $3,070,457 | -43.1% | 664,601 | -0.4% | 0.02% | -47.2% |
Q4 2022 | $5,393,207 | +30.7% | 667,476 | -10.2% | 0.04% | +9.1% |
Q3 2022 | $4,125,000 | -22.2% | 743,228 | -26.9% | 0.03% | -19.5% |
Q2 2022 | $5,299,000 | +3.9% | 1,017,034 | +63.9% | 0.04% | +20.6% |
Q1 2022 | $5,100,000 | +110.2% | 620,480 | +482.2% | 0.03% | +78.9% |
Q1 2021 | $2,426,000 | -29.0% | 106,581 | -32.2% | 0.02% | -36.7% |
Q4 2020 | $3,415,000 | +540.7% | 157,301 | +196.7% | 0.03% | +400.0% |
Q3 2020 | $533,000 | +9.4% | 53,013 | -15.5% | 0.01% | +20.0% |
Q2 2020 | $487,000 | -27.1% | 62,727 | -4.3% | 0.01% | -44.4% |
Q1 2020 | $668,000 | -7.1% | 65,531 | +0.3% | 0.01% | +28.6% |
Q4 2019 | $719,000 | +156.8% | 65,334 | +112.2% | 0.01% | +133.3% |
Q3 2019 | $280,000 | -43.3% | 30,786 | -29.0% | 0.00% | -57.1% |
Q2 2019 | $494,000 | -0.4% | 43,367 | -0.4% | 0.01% | 0.0% |
Q1 2019 | $496,000 | – | 43,526 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |